243 related articles for article (PubMed ID: 34132575)
21. Cloning and analysis of sooty mangabey alternative coreceptors that support simian immunodeficiency virus SIVsmm entry independently of CCR5.
Elliott ST; Riddick NE; Francella N; Paiardini M; Vanderford TH; Li B; Apetrei C; Sodora DL; Derdeyn CA; Silvestri G; Collman RG
J Virol; 2012 Jan; 86(2):898-908. PubMed ID: 22090107
[TBL] [Abstract][Full Text] [Related]
22. Antiretroviral activity and Vif sensitivity of rhesus macaque APOBEC3 proteins.
Virgen CA; Hatziioannou T
J Virol; 2007 Dec; 81(24):13932-7. PubMed ID: 17942564
[TBL] [Abstract][Full Text] [Related]
23. Endogenous origins of HIV-1 G-to-A hypermutation and restriction in the nonpermissive T cell line CEM2n.
Refsland EW; Hultquist JF; Harris RS
PLoS Pathog; 2012; 8(7):e1002800. PubMed ID: 22807680
[TBL] [Abstract][Full Text] [Related]
24. Possible footprints of APOBEC3F and/or other APOBEC3 deaminases, but not APOBEC3G, on HIV-1 from patients with acute/early and chronic infections.
Armitage AE; Deforche K; Welch JJ; Van Laethem K; Camacho R; Rambaut A; Iversen AK
J Virol; 2014 Nov; 88(21):12882-94. PubMed ID: 25165112
[TBL] [Abstract][Full Text] [Related]
25. Vif proteins of human and simian immunodeficiency viruses require cellular CBFβ to degrade APOBEC3 restriction factors.
Hultquist JF; Binka M; LaRue RS; Simon V; Harris RS
J Virol; 2012 Mar; 86(5):2874-7. PubMed ID: 22205746
[TBL] [Abstract][Full Text] [Related]
26. Vif proteins from diverse primate lentiviral lineages use the same binding site in APOBEC3G.
Letko M; Silvestri G; Hahn BH; Bibollet-Ruche F; Gokcumen O; Simon V; Ooms M
J Virol; 2013 Nov; 87(21):11861-71. PubMed ID: 23986590
[TBL] [Abstract][Full Text] [Related]
27. Cellular requirements for bovine immunodeficiency virus Vif-mediated inactivation of bovine APOBEC3 proteins.
Zhang W; Wang H; Li Z; Liu X; Liu G; Harris RS; Yu XF
J Virol; 2014 Nov; 88(21):12528-40. PubMed ID: 25142583
[TBL] [Abstract][Full Text] [Related]
28. Vif substitution enables persistent infection of pig-tailed macaques by human immunodeficiency virus type 1.
Thippeshappa R; Polacino P; Yu Kimata MT; Siwak EB; Anderson D; Wang W; Sherwood L; Arora R; Wen M; Zhou P; Hu SL; Kimata JT
J Virol; 2011 Apr; 85(8):3767-79. PubMed ID: 21289128
[TBL] [Abstract][Full Text] [Related]
29. The activity spectrum of Vif from multiple HIV-1 subtypes against APOBEC3G, APOBEC3F, and APOBEC3H.
Binka M; Ooms M; Steward M; Simon V
J Virol; 2012 Jan; 86(1):49-59. PubMed ID: 22013041
[TBL] [Abstract][Full Text] [Related]
30. Differential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F.
Tian C; Yu X; Zhang W; Wang T; Xu R; Yu XF
J Virol; 2006 Mar; 80(6):3112-5. PubMed ID: 16501124
[TBL] [Abstract][Full Text] [Related]
31. Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all.
Desimmie BA; Delviks-Frankenberrry KA; Burdick RC; Qi D; Izumi T; Pathak VK
J Mol Biol; 2014 Mar; 426(6):1220-45. PubMed ID: 24189052
[TBL] [Abstract][Full Text] [Related]
32. Polymorphisms of the cytidine deaminase APOBEC3F have different HIV-1 restriction efficiencies.
Mohammadzadeh N; Follack TB; Love RP; Stewart K; Sanche S; Chelico L
Virology; 2019 Jan; 527():21-31. PubMed ID: 30448640
[TBL] [Abstract][Full Text] [Related]
33. Vif of feline immunodeficiency virus from domestic cats protects against APOBEC3 restriction factors from many felids.
Zielonka J; Marino D; Hofmann H; Yuhki N; Löchelt M; Münk C
J Virol; 2010 Jul; 84(14):7312-24. PubMed ID: 20444897
[TBL] [Abstract][Full Text] [Related]
34. Identification of a novel WxSLVK motif in the N terminus of human immunodeficiency virus and simian immunodeficiency virus Vif that is critical for APOBEC3G and APOBEC3F neutralization.
Dang Y; Wang X; Zhou T; York IA; Zheng YH
J Virol; 2009 Sep; 83(17):8544-52. PubMed ID: 19535447
[TBL] [Abstract][Full Text] [Related]
35. Examination of the APOBEC3 Barrier to Cross Species Transmission of Primate Lentiviruses.
Gaba A; Flath B; Chelico L
Viruses; 2021 Jun; 13(6):. PubMed ID: 34200141
[TBL] [Abstract][Full Text] [Related]
36. APOBEC3F determinants of HIV-1 Vif sensitivity.
Land AM; Shaban NM; Evans L; Hultquist JF; Albin JS; Harris RS
J Virol; 2014 Nov; 88(21):12923-7. PubMed ID: 25142588
[TBL] [Abstract][Full Text] [Related]
37. Conserved and non-conserved features of HIV-1 and SIVagm Vif mediated suppression of APOBEC3 cytidine deaminases.
Zhang W; Huang M; Wang T; Tan L; Tian C; Yu X; Kong W; Yu XF
Cell Microbiol; 2008 Aug; 10(8):1662-75. PubMed ID: 18419775
[TBL] [Abstract][Full Text] [Related]
38. Species-specific differences in the ability of feline lentiviral Vif to degrade feline APOBEC3 proteins.
Yoshikawa R; Nakano Y; Yamada E; Izumi T; Misawa N; Koyanagi Y; Sato K
Microbiol Immunol; 2016 Apr; 60(4):272-9. PubMed ID: 26935128
[TBL] [Abstract][Full Text] [Related]
39. Genetic characterization of new West African simian immunodeficiency virus SIVsm: geographic clustering of household-derived SIV strains with human immunodeficiency virus type 2 subtypes and genetically diverse viruses from a single feral sooty mangabey troop.
Chen Z; Telfier P; Gettie A; Reed P; Zhang L; Ho DD; Marx PA
J Virol; 1996 Jun; 70(6):3617-27. PubMed ID: 8648696
[TBL] [Abstract][Full Text] [Related]
40. APOBEC3 multimerization correlates with HIV-1 packaging and restriction activity in living cells.
Li J; Chen Y; Li M; Carpenter MA; McDougle RM; Luengas EM; Macdonald PJ; Harris RS; Mueller JD
J Mol Biol; 2014 Mar; 426(6):1296-307. PubMed ID: 24361275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]